GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy ...

Among US adults without diabetes, the use of GLP-1 RAs increased from 2018 to 2022, reaching annual prevalence of 0.4% in 2022.

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Patients using GLP-1 receptor agonists appear to have a lower risk ... compared with other medications such as metformin, insulin, statins, and aspirin in older patients with long-term follow ...

If you are taking a weight loss medication such as Ozempic, Wegovy, or Zepbound for obesity or other health concerns, you may ...

Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...

GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become household names in recent ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the ... while newer GLP-1-targeting drugs like Ozempic and Wegovy, as well as Eli Lilly’s ...

As earlier outlined, short-term studies in animals and humans have shown GLP-1 to have some direct vasorelaxation action, cardioprotective effects in models of ischemia-reperfusion injury ...

Dr. Heather Rosen By Heather Rosen, PhD Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 ...